Ardelyx Stock Alpha and Beta Analysis

ARDX Stock  USD 5.31  0.19  3.71%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ardelyx. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ardelyx over a specified time horizon. Remember, high Ardelyx's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ardelyx's market risk premium analysis include:
Beta
2.37
Alpha
(0.39)
Risk
4.43
Sharpe Ratio
(0.03)
Expected Return
(0.15)
Please note that although Ardelyx alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Ardelyx did 0.39  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Ardelyx stock's relative risk over its benchmark. Ardelyx has a beta of 2.37  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ardelyx will likely underperform. At this time, Ardelyx's Price Book Value Ratio is fairly stable compared to the past year. Price Fair Value is likely to rise to 8.56 in 2024, whereas Book Value Per Share is likely to drop 0.72 in 2024.

Enterprise Value

1.46 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Ardelyx Backtesting, Ardelyx Valuation, Ardelyx Correlation, Ardelyx Hype Analysis, Ardelyx Volatility, Ardelyx History and analyze Ardelyx Performance.
For more information on how to buy Ardelyx Stock please use our How to Invest in Ardelyx guide.

Ardelyx Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ardelyx market risk premium is the additional return an investor will receive from holding Ardelyx long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ardelyx. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ardelyx's performance over market.
α-0.39   β2.37

Ardelyx expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ardelyx's Buy-and-hold return. Our buy-and-hold chart shows how Ardelyx performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Ardelyx Market Price Analysis

Market price analysis indicators help investors to evaluate how Ardelyx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ardelyx shares will generate the highest return on investment. By understating and applying Ardelyx stock market price indicators, traders can identify Ardelyx position entry and exit signals to maximize returns.

Ardelyx Return and Market Media

The median price of Ardelyx for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 5.93 with a coefficient of variation of 9.26. The daily time series for the period is distributed with a sample standard deviation of 0.54, arithmetic mean of 5.88, and mean deviation of 0.39. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending Contact Levi Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDX
10/10/2024
2
Ardelyx CEO Michael Raab sells 45,075 in stock
10/15/2024
3
Compared to Estimates, Ardelyx Q3 Earnings A Look at Key Metrics
10/31/2024
4
Disposition of 27172 shares by David Rosenbaum of Ardelyx at 2.32 subject to Rule 16b-3
11/04/2024
5
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
11/05/2024
6
Ardelyx chief development officer sells shares worth 165,743
11/08/2024
7
Ardelyx shares downgraded amid sales concerns for XPHOZAH
11/11/2024
8
Acquisition by Mott David M of 215868 shares of Ardelyx at 4.6167 subject to Rule 16b-3
11/13/2024
9
Insider Selling Ardelyx, Inc. CEO Sells 2,743 Shares of Stock
11/15/2024
10
Disposition of 4941 shares by Robert Blanks of Ardelyx at 4.7945 subject to Rule 16b-3
11/20/2024
11
Ardelyx chief medical officer sells 35,316 in stock
11/22/2024

About Ardelyx Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ardelyx or other stocks. Alpha measures the amount that position in Ardelyx has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2020 2023 2024 (projected)
Payables Turnover0.02581.62.55
Days Of Inventory On Hand290.97255.33268.09

Ardelyx Upcoming Company Events

As portrayed in its financial statements, the presentation of Ardelyx's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ardelyx's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ardelyx's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ardelyx. Please utilize our Beneish M Score to check the likelihood of Ardelyx's management manipulating its earnings.
7th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Ardelyx

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Ardelyx Stock Analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.